胆汁淤积性肝病的流行病学与经济负担
本文综述了原发性硬化性胆管炎、原发性胆汁性胆管炎和IgG4相关胆管炎的流行病学、健康相关生活质量及经济负担。尽管被归类为罕见病,但这些疾病的发病率缓慢上升,而病毒性肝炎负担正在下降。在许多西方国家,胆汁淤积性肝病目前位列肝移植最常见适应证的前3位。
要点
- 胆汁淤积性肝病主要包括原发性硬化性胆管炎、原发性胆汁性胆管炎和IgG4相关胆管炎。
- 尽管归类为罕见病,这些疾病的发病率缓慢上升,而病毒性肝炎负担正在下降。
- 在许多西方国家,胆汁淤积性肝病位列肝移植最常见适应证的前3位。
核心结论
- 准确理解胆汁淤积性疾病的流行病学及对个体和社会的疾病负担非常重要。
研究设计与样本
- 本文为综述,旨在全面概述当前关于原发性硬化性胆管炎、原发性胆汁性胆管炎和IgG4相关胆管炎的流行病学、健康相关生活质量和经济负担的文献。
主要发现
- 胆汁淤积性肝病主要包括原发性硬化性胆管炎、原发性胆汁性胆管炎和IgG4相关胆管炎。
- 尽管被归类为罕见病,但这些疾病的发病率缓慢上升,而病毒性肝炎负担正在下降。
- 在许多西方国家,胆汁淤积性肝病目前位列肝移植最常见适应证的前3位。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The main cholestatic liver diseases comprise primary sclerosing cholangitis, primary biliary cholangitis, and IgG4-related cholangitis. Despite being classified as rare diseases, these are becoming gradually more important in the field of hepatology since their incidence is slowly rising while the viral hepatitis burden is declining. Cholestatic liver diseases now rank among the 3 most frequent indications for liver transplantation in many Western countries. An accurate understanding of the epidemiology and burden of disease on both the individual and society of cholestatic diseases is of great importance. This review aims to provide a comprehensive overview of the current literature on the epidemiology, health-related quality of life, and economic burden of primary sclerosing cholangitis, primary biliary cholangitis, and IgG4-related cholangitis.
引用
- Mol B, Werner E, Culver EL, et al. Epidemiological and economical burden of cholestatic liver disease. Hepatology. 2025. PMID: 40168457. doi:10.1097/HEP.0000000000001341
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。